CRP, which is produced by hepatocytes in response to IL-6 stimulation, is a cost-effective and widely available marker of inflammation that may also contribute to an immunosuppressive tumour microenvironment by directly impairing T-cell function [19, 20]. The gene discussed is IL6; the disease is neoplasm.